ZTE Surges After the U.S. Frees It to Resume Doing Business
(Bloomberg) -- ZTE Corp. climbed as much as 15 percent after the U.S. formally lifted a ban on its American technology purchases, allowing the Chinese telecoms gear-maker to resume business.
The company's shares marked a month's high in Hong Kong and rose by their 10 percent daily limit in Shenzhen. Washington's decision resolves a months-long moratorium that thrust ZTE into the center of a U.S.-China trade dispute and threatened to choke off the components it needs to make its networking gear and smartphones.
The company had languished in limbo since the U.S. imposed the moratorium in April as punishment for violating Iran and North Korean export sanctions, then lying about it. In return for lifting that ban, ZTE forked over $1.4 billion in penalties, replaced its entire board and agreed to let the U.S. appoint compliance overseers to monitor its business.
ZTE said in a weekend post on social media service Weibo that it would “set out with full confidence” after the U.S. decision. It estimates it could incur a loss of as much as 9 billion yuan ($1.3 billion) for the first half of the year.
“This will push investors to reconsider their overly pessimistic expectations,” Wu Youwen, an analyst with Zhongtai Securities, wrote in a research note. “The communications sector had led market declines since the start of the year. It's fully reflected concerns about shrinking capital expenditure, the ZTE issue and China-U.S. relations.”
U.S. Lifts Ban on China's ZTE After $1.4 Billion Penalty
To contact Bloomberg News staff for this story: Gao Yuan in Beijing at ygao199@bloomberg.net
To contact the editors responsible for this story: Robert Fenner at rfenner@bloomberg.net, Edwin Chan
©2018 Bloomberg L.P.
With assistance from Editorial Board
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.